“Ten-Year Response to Crizotinib in ALK-Positive Inflammatory Myofibroblastic Tumors: Case Reports”. Voprosy Onkologii, vol. 70, no. 2, May 2024, pp. 384-9, https://doi.org/10.37469/0507-3758-2024-70-2-384-389.